Long-term Active Surveillance Study for Oral Contraceptives (LASS)

NCT00676065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58303

Last updated 2014-11-19

Study results available
· View outcomes & findings →

Summary

The objective of this study is to characterize and compare the risks of long-term use of oral contraceptives containing drospirenone and of other established oral contraceptives.

Conditions

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY
  • Center for Epidemiology and Health Research, Germany

    lead OTHER

Principal Investigators

  • Juergen Dinger, MD, PhD · Center for Epidemiology and Health Research Berlin, Germany

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-02-28
Primary Completion
2011-03-31
Completion
2011-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00676065 on ClinicalTrials.gov